TARPEYO 4 MG Delayed Release Oral Capsule

RxCUI: 2587889
RxNorm name: TARPEYO 4 MG Delayed Release Oral Capsule
Display name: TARPEYO 4 MG Delayed Release Oral Capsule
Full name: TARPEYO 4 MG Delayed Release Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tarpeyo	BUDESONIDE	Calliditas Therapeutics AB	938cada4-d6bf-4252-836f-dd40f9eadb4d	2026-01-21	Warnings, Adverse reactions	Exact identifier rxcui: 2587889

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
938cada4-d6bf-4252-836f-dd40f9eadb4d	TARPEYO 4 MG Delayed Release Oral Capsule [PSN] · budesonide 4 MG Delayed Release Oral Capsule [Tarpeyo] [SBD] · Tarpeyo 4 MG Delayed Release Oral Capsule [SY]	3	5	These highlights do not include all the information needed to use TARPEYO safely and effectively. See full prescribing information for TARPEYO. TARPEYO (budesonide) delayed release capsules, for oral use Initial U.S. Approval: 1997	20260121